Pittsburgh, PA, United States

Thar Pharmaceuticals

tharpharma.com
Pittsburgh, PA, United States

Time filter

Source Type

Novel solution complexes of zoledronic acid are described which give rise to improved properties of zoledronic acid. The invention includes aqueous solution and molecular complexes of zoledronic acid with and optical isomers of asparagine, histidine, arginine and proline as well as pharmaceutical complexes containing them and methods of treatment using them.


Patent
Thar Pharmaceuticals | Date: 2013-02-13

Preparation, in-vitro and in vivo characterization of novel forms of (1-hydroxy-2-imidazol-1-yl-1-phosphono-ethyl)phosphonic acid, suitable for pharmaceutical compositions in drug delivery systems for humans.


Patent
Thar Pharmaceuticals | Date: 2015-03-13

Novel solution complexes of zoledronic acid are described which give rise to improved properties of zoledronic acid. The invention includes aqueous solution and molecular complexes of zoledronic acid with and optical isomers of asparagine, histidine, arginine and proline as well as pharmaceutical complexes containing them and methods of treatment using them.


Patent
Thar Pharmaceuticals | Date: 2015-06-04

Preparation and in vitro and in vivo characterization of novel forms of active pharmaceutical ingredients, suitable for pharmaceutical compositions in drug delivery systems for humans.


Patent
Thar Pharmaceuticals | Date: 2013-03-14

Preparation, in-vitro and in vivo characterization of novel forms of (1-hydroxy-2-imidazol-1-yl-1-phosphono-ethyl)phosphonic acid, suitable for pharmaceutical compositions in drug delivery systems for humans.


Patent
Thar Pharmaceuticals | Date: 2012-02-17

The invention is directed to novel crystalline forms of meloxicam. These novel crystalline forms of meloxicam have improved bioavailability, an enhanced rate of dissolution and shorter time to C_(max )in blood, as compared to pure meloxicam.


Patent
Thar Pharmaceuticals | Date: 2016-04-15

Preparation and characterization of novel forms of (1-hydroxy-2-imidazol-1-yl-1-phosphono-ethyl) phosphonic acid, suitable for pharmaceutical compositions in drug delivery systems for humans.


Patent
Thar Pharmaceuticals | Date: 2016-04-19

Preparation, in-vitro and in vivo characterization of novel forms of (1-hydroxy-2-imidazol-1-yl-1-phosphono-ethyl) phosphonic acid, suitable for pharmaceutical compositions in drug delivery systems for humans.


Patent
Thar Pharmaceuticals | Date: 2016-10-07

Preparation and in vitro and in vivo characterization of novel forms of active pharmaceutical ingredients, suitable for pharmaceutical compositions in drug delivery systems for humans.


Patent
Thar Pharmaceuticals | Date: 2013-10-07

Novel crystalline forms of tadalafil suitable for pharmaceutical compositions in drug delivery systems for humans.

Loading Thar Pharmaceuticals collaborators
Loading Thar Pharmaceuticals collaborators